Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/2/2025

Managing Dry Mouth Caused by Vyvanse (Lisdexamfetamine)

First-Line Management Strategies

  • Optimize hydration by increasing water intake throughout the day and limiting caffeine consumption, which can worsen dry mouth symptoms, as recommended by the American College of Physicians, with a strength of evidence level of high 1
  • Use saliva substitutes such as moisture-preserving mouth rinses, sprays, or gels that have a neutral pH and contain electrolytes to mimic natural saliva, with a moderate level of evidence supporting their effectiveness 1
  • Employ salivary stimulants including sugar-free chewing gum, lozenges, or candy to mechanically stimulate saliva production, as suggested by the National Comprehensive Cancer Network, with a low level of evidence 2
  • Implement dietary modifications by avoiding crunchy, spicy, acidic, or hot foods that may exacerbate discomfort, with a moderate level of evidence supporting this approach 2

Second-Line Management Strategies

  • Consider saliva substitute oral sprays containing xylitol, which can provide temporary relief while also offering protection against dental caries, with a high level of evidence supporting their use 1
  • Use specialized toothpastes and rinses designed for dry mouth that are less irritating and contain fluoride for additional protection, as recommended by the American Dental Association, with a moderate level of evidence 1

Pharmacological Interventions (For Severe Cases)

  • Systemic sialagogues such as pilocarpine (5 mg orally four times daily) or cevimeline may be considered for severe cases not responding to other measures, with a high level of evidence supporting their effectiveness, but requiring careful monitoring due to potential side effects including excessive sweating, nausea, and bronchoconstriction 3, 2
  • Be cautious with sialagogues as they can cause side effects, requiring careful monitoring especially in older adults, with a moderate level of evidence supporting this approach 4

When to Seek Additional Care

  • Consult a healthcare provider if dry mouth symptoms are severe, persistent despite management strategies, or significantly affecting quality of life, as recommended by the National Comprehensive Cancer Network, with a high level of evidence supporting this approach 2
  • Consider dental referral for patients with signs of dental complications from chronic dry mouth, with a moderate level of evidence supporting this approach 2

Treatment Options for Dry Mouth (Xerostomia)

Assessment and Treatment Approach

  • The treatment of dry mouth should be guided by baseline salivary gland function measurement and follows a stepwise approach of non-pharmacological stimulation, pharmacological stimulation, or saliva substitution depending on the severity of glandular dysfunction 5, 6
  • Baseline evaluation of salivary gland function should be performed by measuring whole salivary flows before initiating treatment, as subjective feelings of dryness may not match objective measurements 5
  • Always rule out conditions unrelated to salivary dysfunction such as candidiasis or burning mouth syndrome 5

Treatment Algorithm Based on Severity

  • Non-pharmacological salivary stimulation is recommended as the preferred first-line approach for mild glandular dysfunction: use gustatory stimulants (sugar-free acidic candies, lozenges, xylitol) and mechanical stimulants (sugar-free chewing gum) 5, 6
  • Pharmacological stimulation with muscarinic agonists may be considered for moderate glandular dysfunction 5, 6
  • Cevimeline has a similar mechanism to pilocarpine but may have a better tolerance profile 5
  • Saliva substitution should be the preferred approach for severe glandular dysfunction (no salivary output) 5, 6
  • Saliva substitutes with neutral pH containing fluoride and electrolytes to mimic natural saliva are available as oral sprays, gels, and rinses 5

Monitoring and Pitfalls

  • No evidence suggests that one non-pharmacological intervention is more effective than another for mild dry mouth 5

Management of Xerostomia

Pharmacological Interventions

  • The American College of Gastroenterology recommends cevimeline as an alternative muscarinic agonist with a similar mechanism to pilocarpine but potentially better tolerance profile 7

Saliva Substitutes and Oral Hygiene

  • Topical products containing olive oil, betaine, and xylitol have demonstrated effectiveness in alleviating thirst and xerostomia, as supported by the European Society of Intensive Care Medicine 8, 9
  • The American Cancer Society recommends prescription-strength fluoride toothpaste and remineralizing pastes containing calcium and phosphate for dental protection in patients with xerostomia 10
  • The American Dental Association suggests flossing at least once daily with waxed floss and using a small, ultra-soft-headed, rounded-end bristle toothbrush to minimize gingival trauma, as part of an oral hygiene protocol 10
  • Rinsing vigorously several times daily with a bland rinse is recommended to maintain moisture, remove debris, and reduce plaque accumulation, according to the European Society of Intensive Care Medicine 8, 9

Supportive Measures

  • Heated humidifiers are recommended instead of bubble humidifiers for non-intubated patients receiving high-flow oxygen therapy to reduce mouth and throat dryness, as suggested by the European Society of Intensive Care Medicine 8, 9
  • Applying water-based lip lubricants frequently is advised, while avoiding petroleum-based products that cause drying and cracking, as recommended by the American Cancer Society 10